NORMAL SITUATION

APOTEEK DE PAUW

Company — Normal situation.

Financial year 2023 · Closed on 31/03/2023

Net result3,4 k €+4,5 %over 1 year
Gross margin19,5 k €-66,1 %over 1 year
Equity131,7 k €+2,7 %over 1 year
Workforce0,3 ETP-66,7 %over 1 year

Identity

Source · BCE/KBO

APOTEEK DE PAUW is a company registered in Belgium. It employs on average 0,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0425.132.885
Legal form
Private company with limited liability
Contributed capital
55 280,26 €
Latest accounts
31/03/2023
Average workforce
0,3 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 40 filings

Trend over 17 financial years

20232022202120202019
Income statement
Gross margin19,5 k €57,4 k €59,7 k €15 k €15 k €
EBITDA5,7 k €12,9 k €54,5 k €15 k €15 k €
Operating result4,3 k €3,5 k €45,4 k €5,4 k €13,3 k €
Net result3,4 k €3,3 k €41,8 k €3,2 k €9,4 k €
Balance sheet
Equity131,7 k €128,3 k €125 k €113,2 k €110 k €
Total assets166,1 k €145,7 k €177,1 k €125,9 k €124,7 k €
Cash16,8 k €24,6 k €18,4 k €19,8 k €36,5 k €
Debts34,4 k €17,1 k €52,1 k €12,7 k €14,6 k €
Other
Workforce0,3 ETP0,9 ETP0,7 ETP––

Board of directors

Source · NBB, accounts to 31/03/2023

1 active · 4 ended

Active mandates

PHARMA NASIR

Director · since 13 avril 2016 · 0651.586.018

Represented by SAHRA NASIR

Active

Ended mandates

PHARMA NASIR

Manager · since 13 avril 2016 · 0651.586.018

Represented by SAHRA NASIR

Ended
PHARMA NASIR

Manager · since 13 avril 2016 · 0651.586.018

Represented by SAHRA NASIR

Ended
DANIELLE DE PAUW

Manager · until 30 juin 2016

Ended
DANIELLE DE PAUW

Manager

Ended

Full financial information

Source · NBB
202320222021202020192018
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/04/202201/04/202101/04/202001/04/201901/04/201801/04/2017
Closing of the financial year31/03/202331/03/202231/03/202131/03/202031/03/201931/03/2018
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/10/202323/09/202211/10/202102/10/202024/09/201919/09/2018
General meeting09/09/202310/09/202211/09/202112/09/202014/09/201908/09/2018
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 40 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/03/202309/09/202331/10/2023FrenchPDF
Abridged model31/03/202210/09/202223/09/2022FrenchPDF
Abridged model31/03/202111/09/202111/10/2021FrenchPDF
Abridged model31/03/202012/09/202002/10/2020FrenchPDF
Abridged model31/03/201914/09/201924/09/2019FrenchPDF
Abridged model31/03/201808/09/201819/09/2018FrenchPDF
Abridged model31/03/201709/09/201725/09/2017FrenchPDF
Abridged model31/03/201610/09/201623/09/2016DutchPDF
Abridged model31/03/201512/09/201524/09/2015DutchPDF
Abridged model31/03/201413/09/201406/01/2015DutchPDF
Abridged model31/03/201314/09/201316/09/2013DutchPDF
Abridged model31/03/201208/09/201210/09/2012DutchPDF
Abridged model31/03/201110/09/201114/09/2011DutchPDF
Abridged model31/03/201011/09/201017/09/2010DutchPDF
Abridged model31/03/200912/09/200914/09/2009DutchPDF
Abridged model31/03/200813/09/200815/09/2008FrenchPDF
Abridged model31/03/200708/09/200728/09/2007FrenchPDF
Abridged model31/03/200609/09/200629/09/2006FrenchPDF
Abridged model31/03/200510/09/200507/10/2005DutchPDF
Abridged model31/03/200411/09/200416/09/2004DutchPDF
Abridged model31/03/200313/09/200326/09/2003DutchPDF
Abridged model31/03/200214/09/200208/10/2002DutchPDF
Abridged model31/03/200108/09/200116/11/2001DutchPDF
Abridged model31/03/200002/09/200004/10/2000DutchPDF

View all 40 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2023

1 active · 4 ended

Active mandates

PHARMA NASIR

Director · since 13 avril 2016 · 0651.586.018

Represented by SAHRA NASIR

Active

Ended mandates

PHARMA NASIR

Manager · since 13 avril 2016 · 0651.586.018

Represented by SAHRA NASIR

Ended
PHARMA NASIR

Manager · since 13 avril 2016 · 0651.586.018

Represented by SAHRA NASIR

Ended
DANIELLE DE PAUW

Manager · until 30 juin 2016

Ended
DANIELLE DE PAUW

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution09/11/2023
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring01/09/2023
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates28/04/2016
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2023
    Annual accounts 20233,4 k €↑
  2. 2022
    Annual accounts 20223,3 k €↓
  3. 2021
    Annual accounts 202141,8 k €↑
  4. 2020
    Annual accounts 20203,2 k €↓
  5. 2019
    Annual accounts 20199,4 k €↑
  6. 2018
    Annual accounts 20184,6 k €↑
  7. 2017
    Annual accounts 201738,9 €↓
  8. 2016
    Annual accounts 20169,8 k €↑
  9. 2015
    Annual accounts 20156,6 k €↑
  10. 2014
    Annual accounts 20144,9 k €↑
  11. 2013
    Annual accounts 20133,7 k €↓
  12. 2012
    Annual accounts 201214,5 k €↑
  13. 2011
    Annual accounts 20117,5 k €↓
  14. 2010
    Annual accounts 201011,6 k €↓
  15. 2009
    Annual accounts 200913 k €↓
  16. 2008
    Annual accounts 200814,4 k €↑
  17. 2007
    Annual accounts 200713,3 k €